Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Latest Factsheet and Blog

22 Mar 2024 16:54

RNS Number : 0340I
Intl. Biotechnology Trust PLC
22 March 2024

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

Latest Factsheet and Blog

IBT's factsheet for the month ended 29 February 2024 is now available directly via its website. Please click here, then 'latest factsheet'.

The latest blog post, The changing face of biotechnology, from IBT's investment managers Ailsa Craig and Marek Poszepczynski, can be read here: https://www.schroders.com/en-gb/uk/individual/content/the-changing-face-of-biotechnology/

To sign up for IBT updates by email, please click here.

ENDS

Enquiries:

Schroder Investment Management Limited

Augustine Chipungu (Press)

Kirsty Preston

Kerry Higgins (Company Secretary)

020 7658 6000

020 7658 6000

Kaso Legg Communications (Financial PR)

Charles Gorman

Henry Taylor

Effie Aye Maung Hider

IBT@kl-communications.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAQLLFLZXLEBBL

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.